Skip to main content
Top
Published in: Neurological Sciences 1/2021

Open Access 01-01-2021 | Stroke | Original Article

The impact of cigarette smoking in predicting stroke using CHADS2 and CHA2DS2-VASc schemas

Authors: Ming-Liang Zuo, Chun-Mei Li, Yan Deng, Sanjib Bhattacharyya, Ping Shuai, Hung-Fat Tse, Chung-Wah Siu, Li-Xue Yin

Published in: Neurological Sciences | Issue 1/2021

Login to get access

Abstract

Objective

To determine the impact of smoking status in the prediction of stroke using CHADS2 and CHA2DS2-VASc schemes.

Methods

Five hundred twenty-eight consecutive patients with arrhythmic symptoms and without any documented arrhythmia from Queen Mary Hospital, Hong Kong, were followed up to determine the incidence of ischemic stroke, new-onset atrial fibrillation (AF), or all-cause mortality. Smoking status was classified into nonsmokers and smokers. The pairwise comparisons of C-statistics for outcomes were performed.

Results

During a median follow-up period of 6.2 years, 65 (12.3%) individuals developed ischemic stroke. Smokers experienced higher annual incidence of stroke, a new-onset AF, and all-cause death compare to nonsmokers, with corresponding hazard ratio (HR) of stroke, AF, and all-cause death being 2.51 (95% confidence intervals, CI 1.36als, CIse death bein 1.15a3.24), and 1.95 (95% CI 1.161.95 (95% CIath being 2.51 (95% confidence corr2 and CHA2DS2-VASc for stroke were 0.60 (95% CI 0.51 for stp = 0.09) and 0.59 (95% CI 0.50 (95%, p = 0.15) respectively, whereas the C-statistics of CHADS2 and CHA2DS2-VASc were 0.66 (95% CI 0.61 were 0p = 0.005), 0.75 (95% CI 0.7 CI 0.7p < 0.0001), respectively among nonsmokers. After incorporating smoking, both the CHADS2-smoking and CHA2DS2-VASc-smoking achieved better C-statistics for new-onset ischemic stroke prediction superior to baseline score systems in male groups.

Conclusion

Cigarette smoking status has impact on stroke stratification using CHADS2 and CHA2DS2-VASc scheme. The discrimination of the CHADS2 and CHA2DS2-VASc scheme for stroke can be significantly improved if smoking status is additionally considered.
Literature
1.
go back to reference Howard G, Goff DC (2012) Population shifts and the future of stroke: forecasts of the future burden of stroke. Ann N Y Acad Sci 1268:14–20CrossRef Howard G, Goff DC (2012) Population shifts and the future of stroke: forecasts of the future burden of stroke. Ann N Y Acad Sci 1268:14–20CrossRef
2.
go back to reference Stroke Risk in Atrial Fibrillation Working G (2008) Comparison of 12 risk stratification schemes to predict stroke in patients with nonvalvular atrial fibrillation. Stroke 39(6):1901–1910CrossRef Stroke Risk in Atrial Fibrillation Working G (2008) Comparison of 12 risk stratification schemes to predict stroke in patients with nonvalvular atrial fibrillation. Stroke 39(6):1901–1910CrossRef
3.
go back to reference Lip GY, Nieuwlaat R, Pisters R, Lane DA, Crijns HJ (2010) Refining clinical risk stratification for predicting stroke and thromboembolism in atrial fibrillation using a novel risk factor-based approach: the euro heart survey on atrial fibrillation. Chest 137(2):263–272CrossRef Lip GY, Nieuwlaat R, Pisters R, Lane DA, Crijns HJ (2010) Refining clinical risk stratification for predicting stroke and thromboembolism in atrial fibrillation using a novel risk factor-based approach: the euro heart survey on atrial fibrillation. Chest 137(2):263–272CrossRef
4.
go back to reference Hasegawa Y, Setoguchi T, Sakaida T, Iuchi T (2020) Utility of a scoring system for differentiating cancer-associated stroke from cryptogenic stroke in patients with cancer. Neurol Sci 41:1245–1250CrossRef Hasegawa Y, Setoguchi T, Sakaida T, Iuchi T (2020) Utility of a scoring system for differentiating cancer-associated stroke from cryptogenic stroke in patients with cancer. Neurol Sci 41:1245–1250CrossRef
5.
go back to reference Goldstein LB, Bushnell CD, Adams RJ et al (2011) Guidelines for the primary prevention of stroke: a guideline for healthcare professionals from the American Heart Association/American Stroke Association. Stroke 42(2):517–584CrossRef Goldstein LB, Bushnell CD, Adams RJ et al (2011) Guidelines for the primary prevention of stroke: a guideline for healthcare professionals from the American Heart Association/American Stroke Association. Stroke 42(2):517–584CrossRef
6.
go back to reference Goldstein LB, Adams R, Alberts MJ, Appel LJ, Brass LM, Bushnell CD, Culebras A, DeGraba T, Gorelick PB, Guyton JR, Hart RG, Howard G, Kelly-Hayes M, Nixon JV, Sacco RL, American Heart Association, American Stroke Association Stroke Council (2006) Primary prevention of ischemic stroke: a guideline from the American Heart Association/American Stroke Association Stroke Council: cosponsored by the Atherosclerotic Peripheral Vascular Disease Interdisciplinary Working Group; Cardiovascular Nursing Council; Clinical Cardiology Council; Nutrition, Physical Activity, and Metabolism Council; and the Quality of Care and Outcomes Research Interdisciplinary Working Group. Circulation 113(24):e873–e923PubMed Goldstein LB, Adams R, Alberts MJ, Appel LJ, Brass LM, Bushnell CD, Culebras A, DeGraba T, Gorelick PB, Guyton JR, Hart RG, Howard G, Kelly-Hayes M, Nixon JV, Sacco RL, American Heart Association, American Stroke Association Stroke Council (2006) Primary prevention of ischemic stroke: a guideline from the American Heart Association/American Stroke Association Stroke Council: cosponsored by the Atherosclerotic Peripheral Vascular Disease Interdisciplinary Working Group; Cardiovascular Nursing Council; Clinical Cardiology Council; Nutrition, Physical Activity, and Metabolism Council; and the Quality of Care and Outcomes Research Interdisciplinary Working Group. Circulation 113(24):e873–e923PubMed
7.
go back to reference Aune D, Schlesinger S, Norat T, Riboli E (2018) Tobacco smoking and the risk of atrial fibrillation: a systematic review and meta-analysis of prospective studies. Eur J Prev Cardiol 25(13):1437–1451CrossRef Aune D, Schlesinger S, Norat T, Riboli E (2018) Tobacco smoking and the risk of atrial fibrillation: a systematic review and meta-analysis of prospective studies. Eur J Prev Cardiol 25(13):1437–1451CrossRef
8.
go back to reference Hu M, Yin H, Shu X, Jia Y, Leng M, Chen L (2019) Multi-angles of smoking and mild cognitive impairment: is the association mediated by sleep duration? Neurol Sci 40(5):1019–1027CrossRef Hu M, Yin H, Shu X, Jia Y, Leng M, Chen L (2019) Multi-angles of smoking and mild cognitive impairment: is the association mediated by sleep duration? Neurol Sci 40(5):1019–1027CrossRef
9.
go back to reference Biancari F, Asim Mahar MA, Kangasniemi OP (2013) CHADS2 and CHA2DS2-VASc scores for prediction of immediate and late stroke after coronary artery bypass graft surgery. J Stroke Cerebrovasc Dis 22(8):1304–1311CrossRef Biancari F, Asim Mahar MA, Kangasniemi OP (2013) CHADS2 and CHA2DS2-VASc scores for prediction of immediate and late stroke after coronary artery bypass graft surgery. J Stroke Cerebrovasc Dis 22(8):1304–1311CrossRef
10.
go back to reference Chan YH, Yiu KH, Lau KK, Yiu YF, Li SW, Lam TH, Lau CP, Siu CW, Tse HF (2014) The CHADS2 and CHA2DS2-VASc scores predict adverse vascular function, ischemic stroke and cardiovascular death in high-risk patients without atrial fibrillation: role of incorporating PR prolongation. Atherosclerosis 237(2):504–513CrossRef Chan YH, Yiu KH, Lau KK, Yiu YF, Li SW, Lam TH, Lau CP, Siu CW, Tse HF (2014) The CHADS2 and CHA2DS2-VASc scores predict adverse vascular function, ischemic stroke and cardiovascular death in high-risk patients without atrial fibrillation: role of incorporating PR prolongation. Atherosclerosis 237(2):504–513CrossRef
11.
go back to reference Mitchell LB, Southern DA, Galbraith D et al (2014) Prediction of stroke or TIA in patients without atrial fibrillation using CHADS2 and CHA2DS2-VASc scores. Heart 100(19):1524–1530CrossRef Mitchell LB, Southern DA, Galbraith D et al (2014) Prediction of stroke or TIA in patients without atrial fibrillation using CHADS2 and CHA2DS2-VASc scores. Heart 100(19):1524–1530CrossRef
12.
go back to reference Zuo ML, Liu S, Chan KH et al (2013) The CHADS2 and CHA 2DS 2-VASc scores predict new occurrence of atrial fibrillation and ischemic stroke. J Interv Card Electrophysiol 37(1):47–54CrossRef Zuo ML, Liu S, Chan KH et al (2013) The CHADS2 and CHA 2DS 2-VASc scores predict new occurrence of atrial fibrillation and ischemic stroke. J Interv Card Electrophysiol 37(1):47–54CrossRef
13.
go back to reference Bossard M, Granger CB, Tanguay JF, Montalescot G, Faxon DP, Jolly SS, Widimsky P, Niemela K, Steg PG, Natarajan MK, Gao P, Fox KAA, Yusuf S, Mehta SR (2017) Double-dose versus standard-dose clopidogrel according to smoking status among patients with acute coronary syndromes undergoing percutaneous coronary intervention. J Am Heart Assoc 6(11) Bossard M, Granger CB, Tanguay JF, Montalescot G, Faxon DP, Jolly SS, Widimsky P, Niemela K, Steg PG, Natarajan MK, Gao P, Fox KAA, Yusuf S, Mehta SR (2017) Double-dose versus standard-dose clopidogrel according to smoking status among patients with acute coronary syndromes undergoing percutaneous coronary intervention. J Am Heart Assoc 6(11)
14.
go back to reference Kelly TN, Gu D, Chen J et al (2008) Cigarette smoking and risk of stroke in the Chinese adult population. Stroke 39(6):1688–1693CrossRef Kelly TN, Gu D, Chen J et al (2008) Cigarette smoking and risk of stroke in the Chinese adult population. Stroke 39(6):1688–1693CrossRef
15.
go back to reference Hankey GJ (2005) Preventable stroke and stroke prevention. J Thromb Haemost 3(8):1638–1645CrossRef Hankey GJ (2005) Preventable stroke and stroke prevention. J Thromb Haemost 3(8):1638–1645CrossRef
16.
go back to reference Goldstein LB, Adams R, Alberts MJ et al (2006) Primary prevention of ischemic stroke: a guideline from the American Heart Association/American Stroke Association Stroke Council: cosponsored by the Atherosclerotic Peripheral Vascular Disease Interdisciplinary Working Group; Cardiovascular Nursing Council; Clinical Cardiology Council; Nutrition, Physical Activity, and Metabolism Council; and the Quality of Care and Outcomes Research Interdisciplinary Working Group: the American Academy of Neurology affirms the value of this guideline. Stroke 37(6):1583–1633CrossRef Goldstein LB, Adams R, Alberts MJ et al (2006) Primary prevention of ischemic stroke: a guideline from the American Heart Association/American Stroke Association Stroke Council: cosponsored by the Atherosclerotic Peripheral Vascular Disease Interdisciplinary Working Group; Cardiovascular Nursing Council; Clinical Cardiology Council; Nutrition, Physical Activity, and Metabolism Council; and the Quality of Care and Outcomes Research Interdisciplinary Working Group: the American Academy of Neurology affirms the value of this guideline. Stroke 37(6):1583–1633CrossRef
17.
go back to reference Glymour MM, Defries TB, Kawachi I, Avendano M (2008) Spousal smoking and incidence of first stroke: the Health and Retirement Study. Am J Prev Med 35(3):245–248CrossRef Glymour MM, Defries TB, Kawachi I, Avendano M (2008) Spousal smoking and incidence of first stroke: the Health and Retirement Study. Am J Prev Med 35(3):245–248CrossRef
18.
go back to reference Glymour MM, Avendano M (2009) Can self-reported strokes be used to study stroke incidence and risk factors?: evidence from the health and retirement study. Stroke 40(3):873–879CrossRef Glymour MM, Avendano M (2009) Can self-reported strokes be used to study stroke incidence and risk factors?: evidence from the health and retirement study. Stroke 40(3):873–879CrossRef
19.
go back to reference Sherif MA, Nienaber CA, Toelg R et al (2011) Impact of smoking on the outcome of patients treated with drug-eluting stents: 1-year results from the prospective multicentre German Drug-Eluting Stent Registry (DES.DE). Clin Res Cardiol 100(5):413–423CrossRef Sherif MA, Nienaber CA, Toelg R et al (2011) Impact of smoking on the outcome of patients treated with drug-eluting stents: 1-year results from the prospective multicentre German Drug-Eluting Stent Registry (DES.DE). Clin Res Cardiol 100(5):413–423CrossRef
20.
go back to reference Kumagai N, Origasa H, Nagao T, Takekawa H, Okuhara Y, Yamaguchi T (2013) Prognostic significance of smoking in patients with acute ischemic stroke within 3 months of onset. J Stroke Cerebrovasc Dis 22(6):792–798CrossRef Kumagai N, Origasa H, Nagao T, Takekawa H, Okuhara Y, Yamaguchi T (2013) Prognostic significance of smoking in patients with acute ischemic stroke within 3 months of onset. J Stroke Cerebrovasc Dis 22(6):792–798CrossRef
21.
go back to reference Edjoc RK, Reid RD, Sharma M, Fang J, Registry of the Canadian Stroke N (2013) The prognostic effect of cigarette smoking on stroke severity, disability, length of stay in hospital, and mortality in a cohort with cerebrovascular disease. J Stroke Cerebrovasc Dis 22(8):e446–e454CrossRef Edjoc RK, Reid RD, Sharma M, Fang J, Registry of the Canadian Stroke N (2013) The prognostic effect of cigarette smoking on stroke severity, disability, length of stay in hospital, and mortality in a cohort with cerebrovascular disease. J Stroke Cerebrovasc Dis 22(8):e446–e454CrossRef
22.
go back to reference Kornej J, Hindricks G, Kosiuk J, Arya A, Sommer P, Husser D, Rolf S, Richter S, Piorkowski C, Gaspar T, Lip GYH, Bollmann A (2013) Renal dysfunction, stroke risk scores (CHADS2, CHA2DS2-VASc, and R2CHADS2), and the risk of thromboembolic events after catheter ablation of atrial fibrillation: the Leipzig Heart Center AF Ablation Registry. Circ Arrhythm Electrophysiol 6(5):868–874CrossRef Kornej J, Hindricks G, Kosiuk J, Arya A, Sommer P, Husser D, Rolf S, Richter S, Piorkowski C, Gaspar T, Lip GYH, Bollmann A (2013) Renal dysfunction, stroke risk scores (CHADS2, CHA2DS2-VASc, and R2CHADS2), and the risk of thromboembolic events after catheter ablation of atrial fibrillation: the Leipzig Heart Center AF Ablation Registry. Circ Arrhythm Electrophysiol 6(5):868–874CrossRef
23.
go back to reference Hart RG, Pearce LA, McBride R, Rothbart RM, Asinger RW (1999) Factors associated with ischemic stroke during aspirin therapy in atrial fibrillation: analysis of 2012 participants in the SPAF I-III clinical trials. The Stroke Prevention in Atrial Fibrillation (SPAF) Investigators. Stroke 30(6):1223–1229CrossRef Hart RG, Pearce LA, McBride R, Rothbart RM, Asinger RW (1999) Factors associated with ischemic stroke during aspirin therapy in atrial fibrillation: analysis of 2012 participants in the SPAF I-III clinical trials. The Stroke Prevention in Atrial Fibrillation (SPAF) Investigators. Stroke 30(6):1223–1229CrossRef
24.
go back to reference Cetin M, Cakici M, Zencir C et al (2014) Prediction of coronary artery disease severity using CHADS2 and CHA2DS2-VASc scores and a newly defined CHA2DS2-VASc-HS score. Am J Cardiol 113(6):950–956CrossRef Cetin M, Cakici M, Zencir C et al (2014) Prediction of coronary artery disease severity using CHADS2 and CHA2DS2-VASc scores and a newly defined CHA2DS2-VASc-HS score. Am J Cardiol 113(6):950–956CrossRef
25.
go back to reference Modi R, Patted SV, Halkati PC, Porwal S, Ambar S, MR P, Metgudmath V, Sattur A (2017) CHADS-VASc-HSF score - new predictor of severity of coronary artery disease in 2976 patients. Int J Cardiol 228:1002–1006CrossRef Modi R, Patted SV, Halkati PC, Porwal S, Ambar S, MR P, Metgudmath V, Sattur A (2017) CHADS-VASc-HSF score - new predictor of severity of coronary artery disease in 2976 patients. Int J Cardiol 228:1002–1006CrossRef
Metadata
Title
The impact of cigarette smoking in predicting stroke using CHADS2 and CHA2DS2-VASc schemas
Authors
Ming-Liang Zuo
Chun-Mei Li
Yan Deng
Sanjib Bhattacharyya
Ping Shuai
Hung-Fat Tse
Chung-Wah Siu
Li-Xue Yin
Publication date
01-01-2021
Publisher
Springer International Publishing
Published in
Neurological Sciences / Issue 1/2021
Print ISSN: 1590-1874
Electronic ISSN: 1590-3478
DOI
https://doi.org/10.1007/s10072-020-04455-w

Other articles of this Issue 1/2021

Neurological Sciences 1/2021 Go to the issue